HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ras-Mek-Erk signaling regulates Nf1 heterozygous neointima formation.

Abstract
Neurofibromatosis type 1 (NF1) results from mutations in the NF1 tumor-suppressor gene, which encodes neurofibromin, a negative regulator of diverse Ras signaling cascades. Arterial stenosis is a nonneoplastic manifestation of NF1 that predisposes some patients to debilitating morbidity and sudden death. Recent murine studies demonstrate that Nf1 heterozygosity (Nf1(+/-)) in monocytes/macrophages significantly enhances intimal proliferation after arterial injury. However, the downstream Ras effector pathway responsible for this phenotype is unknown. Based on in vitro assays demonstrating enhanced extracellular signal-related kinase (Erk) signaling in Nf1(+/-) macrophages and vascular smooth muscle cells and in vivo evidence of Erk amplification without alteration of phosphatidylinositol 3-kinase signaling in Nf1(+/-) neointimas, we tested the hypothesis that Ras-Erk signaling regulates intimal proliferation in a murine model of NF1 arterial stenosis. By using a well-established in vivo model of inflammatory cell migration and standard cell culture, neurofibromin-deficient macrophages demonstrate enhanced sensitivity to growth factor stimulation in vivo and in vitro, which is significantly diminished in the presence of PD0325901, a specific inhibitor of Ras-Erk signaling in phase 2 clinical trials for cancer. After carotid artery injury, Nf1(+/-) mice demonstrated increased intimal proliferation compared with wild-type mice. Daily administration of PD0325901 significantly reduced Nf1(+/-) neointima formation to levels of wild-type mice. These studies identify the Ras-Erk pathway in neurofibromin-deficient macrophages as the aberrant pathway responsible for enhanced neointima formation.
AuthorsBrian K Stansfield, Waylan K Bessler, Raghuveer Mali, Julie A Mund, Brandon D Downing, Reuben Kapur, David A Ingram Jr
JournalThe American journal of pathology (Am J Pathol) Vol. 184 Issue 1 Pg. 79-85 (Jan 2014) ISSN: 1525-2191 [Electronic] United States
PMID24211110 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Neurofibromin 1
  • ras Proteins
Topics
  • Animals
  • Blotting, Western
  • Carotid Stenosis (metabolism, pathology)
  • Disease Models, Animal
  • MAP Kinase Signaling System (physiology)
  • Macrophages (metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Mutant Strains
  • Neointima (metabolism, pathology)
  • Neurofibromatosis 1 (genetics, metabolism, pathology)
  • Neurofibromin 1 (genetics, metabolism)
  • Signal Transduction (physiology)
  • ras Proteins (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: